| APH1A Protein — Gamma-Secretase Subunit | |
|---|---|
| Gene | APH1A |
| UniProt | Q9Y6X0 |
| PDB Structures | 5A63, 5BS6 |
| Molecular Weight | ~28 kDa |
| Length | 257 amino acids |
| Subcellular Localization | Endoplasmic reticulum, Golgi apparatus, Plasma membrane |
| Protein Family | APH1 family, Gamma-secretase complex |
| Aliases | APH-1, APH1-A, Gamma-secretase subunit APH-1A |
Aph1A Protein Gamma Secretase Subunit is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
APH1A (Anterior Pharynx Defective 1 Homolog A) is a core component of the gamma-secretase complex, a unique aspartyl protease that performs regulated intramembrane proteolysis (RIP) [1]. The protein is encoded by the APH1A gene and is essential for gamma-secretase complex assembly, stability, and function [2].
The gamma-secretase complex is composed of four essential subunits:
APH1A contributes to the proteolytic processing of over 100 type I transmembrane proteins, most notably the amyloid precursor protein (APP), which generates amyloid-beta peptides central to Alzheimer's Disease pathogenesis [3].
APH1A is a polytopic membrane protein with seven transmembrane domains [2]:
N-terminus (luminal)
|
TM1 - TM2 - TM3 - TM4 - TM5 - TM6 - TM7
|
C-terminus (cytoplasmic)
| Feature | Description |
|---|---|
| Transmembrane domains | 7 helical segments |
| N-terminal domain | Lumen-facing, interacts with nicastrin |
| C-terminal domain | Cytoplasmic, involved in complex assembly |
| GxxxG motifs | Dimerization interfaces |
| Glycosylation | N-linked glycosylation in luminal domain |
The gamma-secretase complex has a characteristic "horseshoe" or "C-shaped" structure [4]:
APH1A plays essential roles in complex biogenesis [2]:
The gamma-secretase complex performs RIP on numerous substrates [3]:
| Substrate | Function | Consequence of Cleavage |
|---|---|---|
| APP | Amyloid precursor | Aβ generation (AD) |
| Notch | Developmental signaling | NICD release |
| E-cadherin | Cell adhesion | Signaling |
| ErbB4 | Growth factor | Signaling |
| LRP1 | Lipoprotein receptor | Aβ clearance |
| IL-1R1 | Inflammation | Signaling |
APH1A is widely expressed:
In the brain, gamma-secretase is expressed in neurons and glia.
APH1A is directly implicated in AD through amyloid-beta generation [3][5]:
Gamma-secretase processes Notch receptors, which are oncogenic when dysregulated [6]:
Rather than inhibiting all cleavage, GSMs shift the processing pattern [7]:
| Type | Effect | Status |
|---|---|---|
| NSAID-derived | Reduce Aβ42 | Clinical trials |
| Natural compounds | Various | Research |
| APH1A-selective | Modified specificity | Preclinical |
The study of Aph1A Protein Gamma Secretase Subunit has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.